|
|
| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Serum Integrated Screen Pt.1
Test CodeINTSCR1
Quest Code
16165
CPT Codes
Refer to Maternal Serum, Serum Integrated Screen, Part 2 (test code 16167)<br /> <strong>This test is not available for California patient testing.</strong>
Includes
This will be reported and billed with Maternal Serum, Serum Integrated Screen, Part 2 results.
Preferred Specimen
1.5 mL serum
Minimum Volume
0.8 mL
Instructions
Collect between 9.0 weeks to 13 6/7 weeks.
Must complete patient demographic information using the Maternal Serum Screen Requisition.
Must complete patient demographic information using the Maternal Serum Screen Requisition.
Transport Container
Transport tube
Transport Temperature
Room temperature
Specimen Stability
Room temperature: 14 days
Refrigerated: 14 days
Frozen: 28 days
Refrigerated: 14 days
Frozen: 28 days
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Moderate hemolysis • Gross hemolysis • Lipemia
Methodology
Chemiluminescence (CL) • Immunoassay (IA)
FDA Status
This test code is for non-New York patient testing. For New York patient testing, use test code 16973.
This test is not available for California patient testing.
Setup Schedule
Mon-sat
Report Available
3-4 days
Limitations
Refer to Serum Integrated Screen, Part 2 (test code 16167).
Clinical Significance
When used in conjunction with part 2 testing, to assess maternal risk for carrying a fetus with down syndrome (trisomy 21), trisomy 18, or a neural tube defect. Both part 1 and part 2 are necessary to generate the risk assessment. These types of tests are standard-of-care in obstetrics.
Performing Laboratory
| Quest Diagnostics Nichols Institute-San Juan Capistrano, CA |
| 33608 Ortega Highway |
| San Juan Capistrano, CA 92675-2042 |
